We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, NextEra Energy and Lowe's
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 19, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Thermo Fisher Scientific Inc. (TMO - Free Report) , NextEra Energy, Inc. (NEE - Free Report) and Lowe's Companies, Inc. (LOW - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Thermo Fisher, NextEra Energy and Lowe's
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc., NextEra Energy, Inc. and Lowe's Companies, Inc. These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
Thermo Fisher’s shares have underperformed the Zacks Medical – Instruments industry over the past year (+9.4% vs. +15.7%). The Zacks analyst believes that difficult macroeconomic conditions leading to disruptions in economic activity, global supply chains and labor markets are creating a challenging business environment for Thermo Fisher. Also, over the past few quarters, the company has been experiencing a continuous decline in COVID testing-related demand, with impact especially felt in the Life Science Solution business.
However, recent product launches, including a pre-transplant risk assessment assay and the international CorEvitas Adolescent Atopic Dermatitis, have helped. Also, Thermo Fisher’s continuous efforts to prioritize its partnership with customers to drive innovation and improve patient care bode well.
NextEra’s shares have outperformed the Zacks Utility - Electric Power industry over the past year (+33.2% vs. +19.6%). The Zacks analyst believes that organic projects and acquisitions, renewable projects and efficient cost management is benefiting the company.
Yet, due to the nature of NextEra Energy’s business, it is subject to complex rules and regulations. Risks in operating nuclear power-based generation units, unfavorable weather conditions, and increasing supply costs hinder results.
Shares of Lowe’s have underperformed the Zacks Building Products - Retail industry over the last two years (+28.1% vs. +34.8%). Per the Zacks analyst, market risks, intense competition, and a decline in DIY spending have ailed the stock.
However, improved product availability, timely delivery, and an expanded assortment, complemented by a rewards program have benefited. Strategic growth initiatives such as store expansion and enhanced customer experiences aim to position the company as a top omnichannel retailer.
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, NextEra Energy and Lowe's
For Immediate Release
Chicago, IL – November 19, 2024 – Zacks.com announces the list of Stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Thermo Fisher Scientific Inc. (TMO - Free Report) , NextEra Energy, Inc. (NEE - Free Report) and Lowe's Companies, Inc. (LOW - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Thermo Fisher, NextEra Energy and Lowe's
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc., NextEra Energy, Inc. and Lowe's Companies, Inc. These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Thermo Fisher’s shares have underperformed the Zacks Medical – Instruments industry over the past year (+9.4% vs. +15.7%). The Zacks analyst believes that difficult macroeconomic conditions leading to disruptions in economic activity, global supply chains and labor markets are creating a challenging business environment for Thermo Fisher. Also, over the past few quarters, the company has been experiencing a continuous decline in COVID testing-related demand, with impact especially felt in the Life Science Solution business.
However, recent product launches, including a pre-transplant risk assessment assay and the international CorEvitas Adolescent Atopic Dermatitis, have helped. Also, Thermo Fisher’s continuous efforts to prioritize its partnership with customers to drive innovation and improve patient care bode well.
(You can read the full research report on Thermo Fisher here >>>)
NextEra’s shares have outperformed the Zacks Utility - Electric Power industry over the past year (+33.2% vs. +19.6%). The Zacks analyst believes that organic projects and acquisitions, renewable projects and efficient cost management is benefiting the company.
Yet, due to the nature of NextEra Energy’s business, it is subject to complex rules and regulations. Risks in operating nuclear power-based generation units, unfavorable weather conditions, and increasing supply costs hinder results.
(You can read the full research report on NextEra here >>>)
Shares of Lowe’s have underperformed the Zacks Building Products - Retail industry over the last two years (+28.1% vs. +34.8%). Per the Zacks analyst, market risks, intense competition, and a decline in DIY spending have ailed the stock.
However, improved product availability, timely delivery, and an expanded assortment, complemented by a rewards program have benefited. Strategic growth initiatives such as store expansion and enhanced customer experiences aim to position the company as a top omnichannel retailer.
(You can read the full research report on Lowe’s here >>>)
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.